Prevalence of dementia in users of hormone replacement therapy as defined by prescription data.
about
Validation of multi-stage telephone-based identification of cognitive impairment and dementia.The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.High tofu intake is associated with worse memory in elderly Indonesian men and women.Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias.Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.Physician recognition of cognitive impairment: evaluating the need for improvement.Relation of Blood Pressure to Cognitive Impairment and DementiaEstrogens, episodic memory, and Alzheimer's disease: a critical updateTelephone interview for cognitive status (TICS) screening for clinical trials of physical activity and cognitive training: the seniors health and activity research program pilot (SHARP-P) study.Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States.Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.Cognitive domains associated with performance on the telephone interview for cognitive status-modified.Hormone use and cognitive performance in women of advanced age.Cognitive performance of older women who have survived cancer.Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew.Age-related effects of blood pressure on everyday cognitive function in community-dwelling women.Social network, cognitive function, and dementia incidence among elderly women.
P2860
Q24799729-2B829321-4A09-4883-B11A-313DA929D589Q33275630-AB868357-5CE0-4F22-9108-F230432958B0Q33347115-21C91416-038B-4089-BAF5-DBC0281FA91CQ33761005-9208DAF0-458C-4957-A3A6-08642D9EE44EQ35189725-2B3DBCC5-C0BD-4F1F-84B6-27EBB5DAF35EQ35812769-71A17F56-E32D-49AC-8EF0-C654BBA24464Q35917114-52180208-3329-4B4B-A320-97525DA4E3F4Q36931711-C98C18A7-7094-482D-9ED1-778FF5D6681EQ37320281-81EC306B-E25D-4B70-B3EF-D86476CE9B30Q37389564-FDAF0BA4-47CB-495D-AB40-7A7DA5AEF1C6Q43028519-DD5285BB-C104-4296-842B-26EFC43B531CQ44209896-1172F643-0D2E-446A-9B08-83D60D793ED4Q46155906-86DA74E1-DFCE-4254-B0CF-FD06CBC0D0DAQ46171658-26B03897-D77D-4527-A392-848A6CEEACF5Q46342146-D327BEE1-6235-4352-B969-81281883EB03Q50483528-5B8DEE1F-1E59-4BC9-B2F4-59293C033FC8Q51850322-6C093C68-81F8-443B-B82C-4A95B5607396Q51890277-EAA77BEF-1CA8-4C24-937F-FEB589B8FE47
P2860
Prevalence of dementia in users of hormone replacement therapy as defined by prescription data.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prevalence of dementia in user ...... defined by prescription data.
@ast
Prevalence of dementia in user ...... defined by prescription data.
@en
type
label
Prevalence of dementia in user ...... defined by prescription data.
@ast
Prevalence of dementia in user ...... defined by prescription data.
@en
prefLabel
Prevalence of dementia in user ...... defined by prescription data.
@ast
Prevalence of dementia in user ...... defined by prescription data.
@en
P2093
P2860
P356
P1476
Prevalence of dementia in user ...... defined by prescription data.
@en
P2093
Diana B Petitti
J Galen Buckwalter
Valerie C Crooks
Vicki Chiu
P2860
P304
P356
10.1093/GERONA/57.8.M532
P407
P577
2002-08-01T00:00:00Z